817.263.0007
Skip the phones, message your provider – Use the Patient Portal
Menu

Research

Introduction
Welcome to the Diabetes and Thyroid Center Research page. We started clinical research years ago, and have worked with many pharmaceutical companies. We are a full service research center with an experienced team. Please review the ongoing studies below that are currently enrolling subjects. We are looking for motivated, responsible patients. If you feel you are a candidate for any of the studies below, please send us an email. We will be happy to review your medical history to see if you can be enrolled. Each study is different and looks for specific requirements. Some of these studies have incentives for the subjects.   

If you do not find one that fits, check back often as the studies are updated.  Thanks for checking us out.

Study 1
A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh cardiovascular Risk PatienTs with Hypertriglyceridemia.

View Study Details
Study contact: Maegan



Study 2

A 24 week randomized, double-blind, placebo-controlled, parallel group, efficacy and safety trial of once daily linagliptin, 5 milligrams orally, as add on to basal insulin in elderly Type 2 Diabetes Mellitus patients with insufficient glycaemic control.

View Study Details
Study contact: Trista



Study 3:

A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subject with Type 2 Diabetes Mellitus and Diabetic Nephropathy.

View Study Details
Study contact: Trista


 

Study 4:
A long term, randomized, double blind, placebo-controlled study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 Diabetes Mellitus.

View Study Details
Study contact: Holly